CORT

#3684
Corcept Therapeutics Incorporated - Common Stock
0.6 9 USD
-98.98%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
0.69
0.69
Range Annuel
0.69
89.00
Changement quotidien
-98.98%
Changement Mensuel
-98.52%
Evolution sur 6 mois
-99.11%
Changement Annuel
-99.05%
Clôture Précédente
68.3 8
Open
0.6 9
Low
0.6 9
High
0.6 9
Volume
220
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 74.6 M
  • Employee 730
  • Founded 1998
  • CEO N/A
  • Website www.corcept.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKJG33
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
42.44
ratio cours/chiffre d'affaires
5.48

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Nouvelles